AJN, American Journal of Nursing:
doi: 10.1097/01.NAJ.0000412633.32527.ca
Drug Watch

New Drug for All

Aschenbrenner, Diane S. MS, RN

Collapse Box

Abstract

* Asparaginase Erwinia chrysanthemi (Erwinaze) is a new drug approved for the treatment of acute lymphoblastic leukemia (ALL) in patients allergic to the ALL drugs that are derived from Escherichia coli.

* Erwinaze carries risks of anaphylaxis, severe or hemorrhagic pancreatitis, coagulation abnormalities, and hyperglycemia that can be permanent and require insulin therapy.

© 2012 Lippincott Williams & Wilkins, Inc.

Login

Article Tools

Share

Article Level Metrics